OliX Pharmaceuticals, Inc (KOSDAQ:226950)
106,200
-11,100 (-9.46%)
Oct 12, 2026, 3:30 PM KST
| Market Cap | 2.42T +31.0% |
| Revenue (ttm) | 13.64B +80.9% |
| Net Income | -14.03B |
| EPS | -662.79 |
| Shares Out | 22.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 186,417 |
| Open | 116,800 |
| Previous Close | 117,300 |
| Day's Range | 105,600 - 117,100 |
| 52-Week Range | 84,000 - 217,000 |
| Beta | 0.40 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 13, 2026 |